That just shows desperation for new shares. June revenue numbers out soon, and must have missed the last twenty PRs about aggressive expansion agenda and growth of RXMD as a company. New location with ramped up sales and Benchmark Investment Banking Firm, who's analysts are featured on CNBC very frequently. This is a highly reputable and recommended form with a huge list of clients. RXMD is not playing any games. Some will be caught with empty pockets in terms of shares.